U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 31 - 40 of 89

Non-prescription ('Over-the-Counter') Naloxone Frequently Asked Questions

The following questions and answers provide details about purchasing and using Narcan 4mg naloxone hydrochloride nasal spray specifically, health plan coverage, training resources, other formulations of naloxone available, and federal grant funding aimed toward increasing access to naloxone in communities across the country.

Format
Web Page
Audience
Communities
Families
Patients
Schools
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
Web Page

State Unintentional Drug Overdose Reporting System (SUDORS)

SUDORS provides comprehensive data on unintentional and undetermined intent drug overdose deaths collected from death certificates and medical examiner/coroner reports.
Format
Web Page
Audience
States
Policymakers and Payers
Communities
Source
Centers for Disease Control and Prevention (CDC)
Year
Resource Type
Web Page

What is Fentanyl?

This fact sheet includes a basic description of fentanyl, a brief explanation of the danger, and strategies to helped loved ones who may be using or at risk of using fentanyl.
Format
Fact Sheet/Brochure
Audience
Patients
Families
Communities
Schools
Source
Partnership to End Addiction
Year
Resource Type
Web Page

Wounds, Withdrawal, and Overdose: What to Expect from Xylazine Drug Supply Adulteration

This 75-minute on-demand session from the ASAM 54th Annual Conference addresses the pharmacology, toxicology, diagnostic testing, and epidemiology of xylazine in exposures. The session includes didactic content, case-based narrative, review of literature, and panel discussion to review important topics about the emerging xylazine crisis in the US.
Format
Web-Based Course
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
American Society of Addiction Medicine (ASAM)
Year
Resource Type
Video

Fentanyl Drug Checking and Screening: Roundtable on Clinical Perspectives Summary Report (PDF - 562 KB)

This document summarizes the discussion from the meeting of clinicians and researchers who are knowledgeable about screening for fentanyl and other drugs, primarily in health care settings. The focus of the meeting was to understand clinician/researcher perspectives about clinical fentanyl testing and distribution of fentanyl test strips (FTS) to patients and discuss next steps for technology development, research, and practice.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF

Fentanyl Drug Checking and Screening: Roundtable on Community Perspectives Summary Report (PDF - 593 KB)

These proceedings summarize the discussion from the harm reduction community roundtable and supplemental individual interviews, inclusive of representatives from national and local harm reduction organizations, state and local government agencies, tribal organizations, and researchers who have experience distributing fentanyl test strips (FTS) or are knowledgeable about FTS specifically or drug checking more generally.

Format
Report/Paper/Issue Brief
Audience
Behavioral Health Providers
Communities
Medical Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF